4 weeks Kiniksa Pharmaceuticals (KNSA) Soars 5.8%: Is Further Upside Left in the Stock? Zacks

Kiniksa Pharmaceuticals (KNSA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Pharmaceuticals

4 weeks Kiniksa Pharmaceuticals (KNSA) Soars 5.8%: Is Further Upside Left in the Stock? Zacks

4 hours LXRX Stock Moves Up 30% in a Week: What is Driving This Rally? Zacks

4 hours Is Regeneron Pharmaceuticals, Inc. (REGN) The Most Profitable Biotech Stock To Buy Right Now? Yahoo Finance

5 hours APLS’ Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag Zacks

5 hours Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen Yahoo Finance

6 hours What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice? Yahoo Finance

1 day Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? Zacks

1 day Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive? Zacks

1 day Here’s Why Verrica Pharmaceuticals (VRCA) Is a Great ‘Buy the Bottom’ Stock Now Zacks

1 day SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States Zacks

2 days Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today Yahoo Finance

2 days JAZZ or ARGX: Which Is the Better Value Stock Right Now? Zacks

2 days Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!” Yahoo Finance

3 days Regeneron Pharmaceuticals, Inc. (REGN): Among Blue Chip Stocks to Invest in at 52-Week Lows Yahoo Finance

4 days Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy? Yahoo Finance

5 days Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March? Yahoo Finance

5 days Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? Yahoo Finance

5 days Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know Zacks

5 days Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound? Zacks

5 days Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report? Zacks

5 days Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It’s Not For A GLP-1 Investor's Business Daily

5 days Corvus Pharmaceuticals’ Short Runway Overshadows Soquelitinib’s Promising Trials Seeking Alpha

5 days Corvus Pharmaceuticals: Now At Cruising Altitude Seeking Alpha

6 days Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks

6 days Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound? Zacks

1 week All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy Zacks

The Stock Market News